Therapeutic Potential of a Vasopressin V2 Receptor Antagonist for Calcium Channel Blocker-Associated Edema with Vasospastic Angina

Figure 1

Photographs of the lower extremities. (a) Severe edema of the lower extremities. (b) Pitting edema in a magnified area of (a). (c) Tolvaptan reduced edema without side effects, leading to a body weight decrease of 12 kg.

(a)

(b)

(c)